Tirilazad for acute ischaemic stroke.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD002087PMID 11687138
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

  2018cited by this paper
• Antiplatelet therapy for acute ischaemic stroke.

  2008cited by this paper
• Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke.

  2004cited by this paper
• The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke

  2002cited by this paper
• Corticosteroids for acute ischaemic stroke.

  2000cited by this paper
• A predictive risk model for outcomes of ischemic stroke.

  2000cited by this paper
• Tirilazad mesylate in acute ischemic stroke - A systematic review

  2000cited by this paper
• Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.

  2000cited by this paper
• Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist.

  2000cited by this paper
• Calcium antagonists for acute ischemic stroke.

  2000cited by this paper
• Prostacyclin and analogues for acute ischaemic stroke.

  2000cited by this paper
• Thrombolysis for acute ischaemic stroke.

  2000cited by this paper
• Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke.

  2000cited by this paper
• Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke.

  1999cited by this paper
• A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.

  1999cited by this paper
• Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators.

  1999cited by this paper
• Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

  1999cited by this paper
• Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial

  1999cited by this paper
• Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America.

  1999cited by this paper
• Clinical stroke trials: guarding against bias.

  1999cited by this paper
• Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.

  1999cited by this paper
• A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury

  1998cited by this paper
• High-dose tirilazad for acute stroke (RANTTAS II). RANTTAS II Investigators.

  1998cited by this paper
• Quality of full and final publications reporting acute stroke trials: a systematic review.

  1998cited by this paper
• Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed.

  1997cited by this paper
• Pharmacokinetics of tirilazad in healthy male subjects at doses above 6 mg/kg/day.

  1997cited by this paper
• Termination of Acute Stroke Studies Involving Selfotel Treatment

  1997cited by this paper
• Pharmacokinetics of tirilazad in healthy male subjects at doses above 6 mg/kg/day.

  1997cited by this paper
• A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.

  1997cited by this paper
• The concept of combination therapy in acute ischemic stroke

  1997cited by this paper
• Effect of early treatment with tirilazad (U74006F) combined with delayed thrombolytic therapy in rat embolic stroke

  1996cited by this paper
• A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators.

  1996cited by this paper
• Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome.

  1996cited by this paper
• Why do all drugs work in animals but none in stroke patients? 1. Drugs promoting cerebral blood flow.

  1995cited by this paper
• Why do all drugs work in animals but none in stroke patients? 2 Neuroprotective therapy

  1995cited by this paper
• Why do all drugs work in animals but none in stroke patients ? 1 Drugs promoting cerebral blood flow

  1995cited by this paper
• Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS).

  1994cited by this paper
• Intravenous Nimodipine West European Stroke Trial (INWEST) of Nimodipine in the Treatment of Acute Ischaemic Stroke

  1994cited by this paper
• Evaluation of the Pharmacokinetics and Tolerability of Tirilazad Mesylate, a 21‐Aminosteroid Free Radical Scavenger: I. Single‐Dose Administration

  1993cited by this paper
• The Effect of Tirilazad Mesylate (U74006F) on Cerebral Oxygen Consumption, and Reactivity of Cerebral Blood Flow to Carbon Dioxide in Healthy Volunteers

  1993cited by this paper
• Evaluation of the Pharmacokinetics and Tolerability of Tirilazad Mesylate, a 21‐Aminosteroid Free Radical Scavenger: II. Multiple‐Dose Administration

  1993cited by this paper
• Effect of U74006F on forebrain ischemia in rats.

  1991cited by this paper
• The 21-aminosteroid antioxidant tirilazad mesylate, U-74006F, blocks cortical hypoperfusion following spreading depression.

  1991cited by this paper
• Failure of the lipid peroxidation inhibitor U74006F to improve neurological outcome after transient forebrain ischemia in the rat.

  1990cited by this paper
• Effects of a novel 21-amino steroid, U74006F, on the rat pituitary-adrenocortical axis.

  1990cited by this paper
• Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage.

  1989cited by this paper
• 21-Aminosteroid reduces ion shifts and edema in the rat middle cerebral artery occlusion model of regional ischemia.

  1988cited by this paper
• 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils.

  1988cited by this paper
• Effects of the 21-aminosteroid U74006F on experimental head injury in mice.

  1988cited by this paper
• Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury.

  1988cited by this paper
• Assessment of outcome after severe brain damage.

  1975cited by this paper
• Functional evaluation : Barthel index

  1965cited by this paper
• FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

  1965cited by this paper
• Spinal tumors diagnosed during the first year of life; with report of a case.

  1951cited by this paper

• The role of oxidative stress in blood-brain barrier disruption during ischemic stroke: Antioxidants in clinical trials.

  2024cites this paper
• Iron, ferroptosis, and ischemic stroke

  2023influential citation
• AutoDock Koto: A Gradient Boosting Differential Evolution for Molecular Docking

  2023influential citation
• Cerebrolysin for acute ischaemic stroke.

  2023cites this paper
• Sirtuin-1 - Mediated NF-κB Pathway Modulation to Mitigate Inflammasome Signaling and Cellular Apoptosis is One of the Neuroprotective Effects of Intra-arterial Mesenchymal Stem Cell Therapy Following Ischemic Stroke

  2022cites this paper
• Nitric Oxide-Dependent Pathways as Critical Factors in the Consequences and Recovery after Brain Ischemic Hypoxia

  2021cites this paper
• Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review

  2020cites this paper
• Can prospective systematic reviews of animal studies improve clinical translation?

  2020cites this paper
• Cerebrolysin for acute ischaemic stroke.

  2020cites this paper
• The Local and Peripheral Immune Responses to Stroke: Implications for Therapeutic Development

  2020cites this paper
• Are researchers moving away from animal models as a result of poor clinical translation in the field of stroke? An analysis of opinion papers

  2020cites this paper
• The Hazard of Negative (Not Neutral) Trials on Treatment of Acute Stroke: A Review.

  2019cites this paper
• The Extended Barthel Index (EBI) can Be Reported as a Unidimensional Interval-Scaled Metric – A Psychometric Study

  2019cites this paper
• Retrospective harm benefit analysis of pre-clinical animal research for six treatment interventions

  2018cites this paper
• Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.

  2018cites this paper
• Endophytes as a Source of High-Value, Bioactive Metabolites

  2018cites this paper
• ANTIOXIDANTS A DISTRESS

  2017cites this paper
• Cerebrolysin for acute ischaemic stroke.

  2017cites this paper
• Cerebrolysin for acute ischaemic stroke.

  2016cites this paper
• Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.

  2016cites this paper
• Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke

  2015cites this paper
• Cerebrolysin for acute ischaemic stroke.

  2015cites this paper
• Small molecule inhibitors in the treatment of cerebral ischemia

  2014cites this paper
• Neurogenesis and Inflammation after Ischemic Stroke: What is Known and Where We Go from Here

  2014cites this paper
• Glutamate as a Neurotoxin

  2014cites this paper
• Oxidative Damage in Clinical Ischemia/Reperfusion Injury: A Reappraisal

  2013cites this paper
• Inflammation and innate immunity in renal ischemia/reperfusion injury

  2013cites this paper
• Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2013cites this paper
• Mesenchymal stromal cells in renal ischemia/reperfusion

  2012cites this paper
• Mesenchymal stromal cells in renal ischemia/reperfusion injury

  2012cites this paper
• Calculation of Numbers-Needed-To-Treat in Parallel Group Trials Assessing Ordinal Outcomes: Case Examples from Acute Stroke and Stroke Prevention

  2011cites this paper
• Stroke management.

  2011cites this paper
• Antioxidant therapy: current status and future prospects.

  2011cites this paper
• Vasoactive drugs for acute stroke.

  2010cites this paper
• Cerebrolysin for acute ischaemic stroke

  2010cites this paper
• Tirilazad for aneurysmal subarachnoid haemorrhage.

  2010cites this paper
• Vasoactive drugs for acute stroke.

  2010cites this paper
• Is There a Future for Neuroprotective Agents in Cardiac Surgery?

  2010cites this paper
• Glutamate receptors, neurotoxicity and neurodegeneration

  2010cites this paper
• Involvement of ROS in BBB dysfunction

  2009cites this paper
• Systematic Reviews as a Tool for Planning and Interpreting Trials

  2009cites this paper
• Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: A systematic review.

  2009cites this paper
• Recommendations and treatment strategies for the management of acute ischemic stroke

  2008cites this paper
• [Effect of combination therapy with hypothermia, magnesium and tirilazad in an experimental model of diffuse cerebral ischemia].

  2007cites this paper
• Protection cérébrale: données expérimentales

  2007cites this paper
• Stroke pathophysiology: management challenges and new treatment advances

  2007cites this paper
• Comparison of treatment effects between animal experiments and clinical trials: systematic review

  2007cites this paper
• Neuroprotective Effects of Free Radical Scavengers in Stroke

  2007cites this paper
• Non-genomic glucocorticoid effects to provide the basis for new drug developments.

  2006cites this paper
• Comparison of treatment effects between animal experiments and clinical trials: systematic review

  2006cites this paper
• Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia

  2005cites this paper
• Pharmacological Strategies for Neurodegeneration and Overview of Clinical Trials

  2004cites this paper
• Strategies of neuroprotection for intracranial aneurysms.

  2004cites this paper
• Acute Ischemic Stroke Treatment: An Emergency B. Therapy

  2003cites this paper
• Concepts of CNS Plasticity in the Context of Brain Damage and Repair

  2003cites this paper
• Neuroprotective agents for the treatment of acute ischemic stroke

  2003cites this paper
• The lazaroid tirilazad is a new inhibitor of direct and indirect UVA-induced lipid peroxidation in human dermal fibroblasts

  2003cites this paper
• Neuroprotection in acute stroke.

  2001cites this paper